Review Of Endo

Low-Dose Doxycycline May Slow Diabetic Retinopathy

From Medscape

Low-dose doxycycline could slow the progression of diabetic retinopathy (DR), according to a small proof-of concept study by a group of researchers in the United States and Denmark, published online March 6 in JAMA Ophthalmology. "To our knowledge, this is the first observation suggesting a link between a low-dose oral anti-inflammatory agent and s...

Read full article

Featured Events